Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Matsuda S, Takeuchi H, Fukuda K, et al. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment. Dis Esophagus. 2014;27:654–61.

    Article  CAS  Google Scholar 

  2. Matsuda S, Takeuchi H, Kawakubo H, et al. Validation study of fibrinogen and albumin score in esophageal cancer patients who underwent esophagectomy: multicenter prospective cohort study. Ann Surg Oncol. 2021;28:774–84.

    Article  Google Scholar 

  3. Hoshino S, Matsuda S, Kawakubo H, et al. Elevation of the prognostic factor plasma fibrinogen reflects the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11974-7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Keio University School of Medicine, Tokyo, Japan

    Shota Hoshino MD, Satoru Matsuda MD, PhD, Hirofumi Kawakubo MD, PhD, Shigeo Yamaguchi MD, PhD, Kazuaki Matsui MD, Tomoyuki Irino MD, PhD, Kazumasa Fukuda PhD, Rieko Nakamura MD, PhD & Yuko Kitagawa MD, PhD

  2. Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan

    Kohei Nakamura MD, PhD, Eriko Aimono MD, PhD & Hiroshi Nishihara MD, PhD

  3. Division of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan

    Hajime Okita MD, PhD

  4. Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan

    Hiroya Takeuchi MD, PhD

Authors
  1. Shota Hoshino MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoru Matsuda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirofumi Kawakubo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shigeo Yamaguchi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kohei Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eriko Aimono MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuaki Matsui MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomoyuki Irino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazumasa Fukuda PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rieko Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hajime Okita MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hiroshi Nishihara MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Hiroya Takeuchi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yuko Kitagawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoru Matsuda MD, PhD.

Ethics declarations

Disclosure

Yuko Kitagawa received lecture fees from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Factory, Inc., Shionogi & Co., Ltd., Nippon Covidien, Inc., Ono Pharmaceutical Co., Ltd., and Bristol-Myers Squibb K.K, and was supported by grants from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd, Yakult Honsha Co., Ltd., AsahiKasei Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma, Inc., Toyama Chemical Co., Ltd., Medicon, Inc., Kaken Pharmaceutical Co. Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory, Inc., Teijin Pharma, Ltd., Nihon Pharmaceutical Co., Ltd., and Nippon Covidien Inc. Yuko Kitagawa held an endowed chair provided by Chugai Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Co., Ltd, outside the submitted work. The remaining authors have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoshino, S., Matsuda, S., Kawakubo, H. et al. ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?. Ann Surg Oncol 29, 6905–6906 (2022). https://doi.org/10.1245/s10434-022-12040-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12040-y

Search

Navigation